Cipher Pharmaceuticals Stock Forward View - Unknown Technical Ratio
| CPH Stock | CAD 14.81 -0.35 -2.31% |
Momentum 50
Impartial
Oversold | Overbought |
Quarterly Earnings Growth 20 | EPS Estimate Next Quarter 0.295 | EPS Estimate Current Year 0.954 | EPS Estimate Next Year 0.869 | Wall Street Target Price 19.2 |
This summary links Cipher Pharmaceuticals' attention patterns to recent price behavior and peer context.
Cipher Pharmaceuticals after-hype prediction price | CAD 14.79 |
The module provides attention context in addition to forecasting models, technical indicators, analyst estimates, and earnings trends.
Cipher |
Cipher Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Cipher price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cipher using various technical indicators. When you analyze Cipher charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check Cipher Pharmaceuticals Volatility | Backtest Cipher Pharmaceuticals | Information Ratio |
Cipher Pharmaceuticals Trading Date Momentum
| On March 09 2026 Cipher Pharmaceuticals was traded for 14.81 at the closing time. The maximum traded price for the trading interval was 15.02 and the lowest daily price was 14.60 . The daily volume was recorded at 23.7 K. The volume of trading on 9th of March 2026 did not affect price variability. The overall trading delta to the closing price today is 1.35% . |
| Compare Cipher Pharmaceuticals to competition |
Other Forecasting Options for Cipher Pharmaceuticals
Investors evaluating Cipher at any level of experience must contend with the challenge of understanding Cipher Pharmaceuticals' price movement. The presence of noise in Cipher Stock price charts can significantly complicate investment decisions.Cipher Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cipher Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Cipher Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Cipher Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Cipher Pharmaceuticals Market Strength Events
For investors tracking Cipher Pharmaceuticals, market strength indicators offer a quantitative way to evaluate how the stock behaves under varying market conditions. These metrics are widely used to refine market timing and identify the most favorable moments to trade Cipher Pharmaceuticals.
Cipher Pharmaceuticals Risk Indicators
Analyzing Cipher Pharmaceuticals' basic risk indicators provides investors with a structured view of the risk-return trade-off associated with cipher stock. Forecasting Cipher Pharmaceuticals' future price accurately requires understanding and quantifying the risks present in the investment.
| Mean Deviation | 1.28 | |||
| Semi Deviation | 1.32 | |||
| Standard Deviation | 1.71 | |||
| Variance | 2.92 | |||
| Downside Variance | 1.99 | |||
| Semi Variance | 1.73 | |||
| Expected Short fall | -1.60 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Cipher Pharmaceuticals
Coverage intensity for Cipher Pharmaceuticals matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Other Macroaxis Stories
Story coverage on Macroaxis is built for readers who approach markets from different levels of experience but share the same need for disciplined investment context. Used well, these stories become part of a broader workflow built around idea generation, validation, and risk-adjusted portfolio design.
Story Categories
Currently Trending Categories
Cipher Pharmaceuticals Short Properties
Short sentiment tied to Cipher Pharmaceuticals matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 24.6 M | |
| Cash And Short Term Investments | 17.8 M |
More Resources for Cipher Stock Analysis
Other Information on Investing in Cipher Stock
Cipher Pharmaceuticals financial ratios help frame valuation context across profits, cash flow, and enterprise value. They help compare Cipher across valuation measures and peers.